PureTech Health PLC (LSE:PRTC) - Share price


Stock Report

PureTech Health PLC PRTC

Last Price
GBX266.84

Day Change
-5.17|-1.90%

As of 03/08/2020
13:24:48 BST | GBX
Minimum 15 Minutes Delay.

Last Close272.00p
Day Range265.00 - 284.50
Mkt Cap776.60Mil
52-Wk Range191.20 - 339.36
Yield %-
ISINGB00BY2Z0H74
Volume62,214
P/E2.48
P/S78.48
P/CF-7.94

Share Price

Total Returns 31/07/2020

 Chg (%)  
More ...
PureTech Health PLC2.45 
FTSE 100 TR GBP-4.20
 
Financials
201720182019
More ...
Income Statement
Turnover2.5420.759.81
Operating Profit-115.42-104.02-135.40
Net Profit-75.09-70.66366.07
Reported EPS0.11-0.161.44
Balance Sheet
Current Assets198.11259.79168.85
Non Current Assets141.74181.98772.33
Total Assets339.85441.76941.18
Current Liabilities273.86265.76139.20
Total Liabilities---
Total Equity59.60166.97650.40
Cash Flow
Operating Cash Flow-88.69-72.80-98.16
Net Change in Cash9.6944.4515.41
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
18/06/2020Transfer inMs. Daphna Zohar0.001,362,3930.00
18/06/2020Transfer inMr. Stephen Muniz0.00455,0390.00
20/05/2020PurchaseDr. John L. Lamattina250.006,70016,750.00
18/05/2020PurchaseDr. John L. Lamattina246.008,20120,174.00

Company Profile

PureTech Health PLC is a cross-disciplinary healthcare company developing products that could improve the lives of patients.

Sector

Biotechnology

Index

FTSE 250 ,FTSE 350 ,FTSE SmallCap ,FTSE All Share

Next Event 27/08/2020

Half-Yearly Results
Ratios
Comp
More ...
PER (E)2.48
Div Yld (E)0.00
PEG (E)0.00
ROCE59.99
Op Mrgn-13.81
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Bennett M. Shapiro
Non-Executive DirectorDr. John L. Lamattina
Non-Executive DirectorDr. Robert S. Langer
Non-Executive DirectorDr. Raju S. Kucherlapati
Non-Executive DirectorDame Marjorie Morris Scardino
Non-Executive Director, Chairman (Interim)Mr. Christopher Viehbacher
Executive Director, Chief Executive OfficerMs. Daphna Zohar
Executive Director, Chief Operating Officer and Company SecretaryMr. Stephen Muniz
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.